GE HealthCare Technologies shares are trading lower after UBS downgraded the stock from Neutral to Sell and lowered its price target from $86 to $66.
Portfolio Pulse from Benzinga Newsdesk
GE HealthCare Technologies' stock (GEHC) trades lower following a downgrade by UBS from Neutral to Sell, with a reduced price target from $86 to $66.
November 27, 2023 | 2:52 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GE HealthCare Technologies' stock price is likely to experience downward pressure in the short term due to UBS's downgrade from Neutral to Sell and a significant reduction in the price target.
Analyst downgrades typically lead to a negative perception among investors, potentially causing a sell-off. The substantial decrease in the price target from $86 to $66 by a major financial institution like UBS suggests a bearish outlook on the stock, which can influence investor sentiment and stock price negatively in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100